The effects of adjuvant anastrozole, exemestane, tamoxifen, and toremifene on serum lipids in postmenopausal women with breast cancer - a randomised study.

被引:0
|
作者
Kataja, V
Hietanen, P
Joensuu, H
Ala-Luhtala, T
Asola, R
Kokko, R
Holli, K
机构
[1] Kuopio Univ Hosp, SF-70210 Kuopio, Finland
[2] Univ Helsinki Hosp, Helsinki, Finland
[3] Cent Hosp Seinajoki, Seinajoki, Finland
[4] Cent Hosp Pori, Pori, Finland
[5] Cent Hosp Jyvaskyla, Jyvaskyla, Finland
[6] Tampere Univ Hosp, Tampere, Finland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
634
引用
收藏
页码:S156 / S156
页数:1
相关论文
共 50 条
  • [1] Exemestane after tamoxifen as adjuvant hormonal therapy in postmenopausal women with breast cancer: effects on body composition and lipids
    Francini, G.
    Petrioli, R.
    Montagnani, A.
    Cadirni, A.
    Campagna, S.
    Francini, E.
    Gonnelli, S.
    [J]. BRITISH JOURNAL OF CANCER, 2006, 95 (02) : 153 - 158
  • [2] Exemestane after tamoxifen as adjuvant hormonal therapy in postmenopausal women with breast cancer: effects on body composition and lipids
    G Francini
    R Petrioli
    A Montagnani
    A Cadirni
    S Campagna
    E Francini
    S Gonnelli
    [J]. British Journal of Cancer, 2006, 95 : 153 - 158
  • [3] Effects of toremifene (TOR) and tamoxifen (TAM) on serum lipids in postmenopausal patients with breast cancer
    Kusama, M
    Miyauchi, K
    Aoyama, H
    Sano, M
    Kimura, M
    Mitsuyama, S
    Komaki, K
    Doihara, H
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 (01) : 1 - 8
  • [4] The effects on lipids of a 2-year adjuvant treatment with exemestane after tamoxifen in postmenopausal women with early breast cancer
    Gonnelli, S.
    Montagnani, A.
    Cadirni, A.
    Caffarelli, C.
    Montomoli, M.
    Campagna, M. S.
    Petrioli, R.
    Del Santo, K.
    Cuda, C.
    Nuti, R.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 409 - 409
  • [5] A prospective randomised study of transvaginal ultrasound effects of tamoxifen and exemestane in postmenopausal women with early breast cancer
    Garrone, Ornella
    Bertelli, Gianfilippo
    Principe, Ernesto
    Lewis, Paul D.
    Occelli, Marcella
    Miraglio, Emanuela
    Merlano, Marco C.
    [J]. TUMORI, 2014, 100 (06) : 620 - 624
  • [6] Endocrine effects of tamoxifen plus exemestane in postmenopausal women with breast cancer
    Love, RR
    Hutson, PR
    Havighurst, TC
    Cleary, JF
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (04) : 1500 - 1503
  • [7] Pharmacoeconomic analysis of adjuvant therapy with exemestane, anastrozole, letrozole or tamoxifen in postmenopausal women with operable and estrogen receptor-positive breast cancer
    Gil J.M.
    Rubio-Terrés C.
    del Castillo-Saiz A.
    González P.
    Canorea F.
    [J]. Clinical and Translational Oncology, 2006, 8 (5) : 339 - 348
  • [8] Adjuvant Sequencing of Tamoxifen and Anastrozole Is Superior to Tamoxifen Alone in Postmenopausal Women with Low Proliferating Breast Cancer
    Bago-Horvath, Zsuzsanna
    Rudas, Margaretha
    Dubsky, Peter
    Jakesz, Raimund
    Singer, Christian F.
    Kemmerling, Ralf
    Greil, Richard
    Jelen, Andrea
    Boehm, Gerhard
    Jasarevic, Zerina
    Haid, Anton
    Gruber, Christine
    Poestlberger, Sabine
    Filipits, Martin
    Gnant, Michael
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (24) : 7828 - 7834
  • [9] The effects on lipid serum levels of a 2-year adjuvant treatment with exemestane after tamoxifen in postmenopausal women with early breast cancer
    Montagnani, A.
    Gonnelli, S.
    Cadirni, A.
    Caffarelli, C.
    Del Santo, K.
    Pieropan, C.
    Campagna, M. S.
    Montomoli, M.
    Petrioli, R.
    Nuti, R.
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2008, 19 (08) : 592 - 597
  • [10] Exemestane in the Adjuvant Treatment of Breast Cancer in Postmenopausal Women
    Kittaneh, Muaiad
    Gluck, Stefan
    [J]. BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2011, 5 : 209 - 226